<DOC>
	<DOCNO>NCT00166153</DOCNO>
	<brief_summary>The survival child receive heart transplant greatly improve last ten year . One reason well control rejection . Rejection medication require delicate balance enough medicine work without cause side effect . It goal avoid rejection side effect anti-rejection medicine . Usually several medicine use together prevent rejection . One medicine often Mycophenolic Acid CellceptThis medicine use longer adults child . More information need use child . The dose usually determine patient 's weight body surface area . There early study use Cellcept , none proven relationship blood level drug well work . More also need known drug work anti-rejection drug work boy girl . This study look closely proper dosing , Cellcept work anti-rejection medication , side effect , difference medicine work boys girl . All patient study receive Cellcept blood level drug drawn . Results usual treatment test record evaluated sign rejection . All information analyze . Results study report transplant committee locally nationally .</brief_summary>
	<brief_title>Outcomes Pediatric Heart Transplant Recipients Receiving Cellcept</brief_title>
	<detailed_description>Pediatric heart transplant recipient receive MMF undergo study test measure MPA level HPLC method T-cell subset flow cytometry method . As standard care receive histological grading routine endomyocardial biopsy use International Society Heart Lung Transplantation ( ISHLT ) grade scale . The data obtain standard assessment include medication , echocardiographic report , pre-and post biopsy assessments/physical exam , hospital record inpatient hospitalization , laboratory assessment . Also , information collect patient examine tolerance success ( side effect rejection ) immunosuppressive therapy . In newly transplant patient , study test occur time standard care biopsies typically 1 week , 2 week , 3 week , 4 week , 6 week , 8 week , 3 month , 4 month , 5 month , 6 month , 8 month , 10 month , 12 month . If patient additional visit due rejection change immunosuppression , frequent study test may do per investigator preference . Previously transplant patient study test time standard care visit , usually annually .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Heart Transplant Recipients transplant course study . Age 2 week 18 year Receiving plan receive Mycophenolate mofetil therapy Patient/Family sign informed assent/consent Patients unable follow protocol schedule assessment Patients chronic autoimmune disease Patients receive multiple organ transplant ( i.e . heartliver , heartlung etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>cardiac transplantation</keyword>
	<keyword>pediatrics</keyword>
	<keyword>cardiology</keyword>
	<keyword>drug metabolism</keyword>
</DOC>